Africa Advanced Wound Care Market to exceed $ 406 Mn by 2024

March 11, 2020


According to a recent study titled ‘Africa Advanced Wound Care Market Size By Product, Application, End-use, Industry Analysis Report, Country Outlook, Application Potential, Competitive Market Share & Forecast, 2018 – 2024’, available with Market Study Report LLC, Africa advanced wound care market is anticipated to cross USD 406 million by the year 2024.  
 

Increasing number of patients requiring surgical procedures for wound treatment is anticipated to augment the growth of Africa advanced wound care market during the analysis period. Rising incidences of bacterial, fungal, and viral infections, along with the surging occurrence of STDs such as HIV are fueling the demand for surgical treatment procedures. This factor coupled with increasing number of road incidents will further impel the market growth.
 

Improving healthcare infrastructure on account of support from various organizations such as WHO, in cognizance with growing availability of skilled surgeons, and improvement in distribution network for surgical instruments and wound therapy products are other major factors supporting the growth of advanced wound care market in Africa. In addition, increasing establishment of clinics in rural areas will propel the demand for wound care products during the analysis period. However, high cost associated with technologically advanced wound care therapy devices will hinder the market growth in the coming years.
 

Based on the product, wound therapy devices segment of Africa advanced wound care market accounted for 27% revenue share in 2017 and is presumed to witness a substantial growth during the study period, owing to the emergence of advanced wound therapy devices which aid in faster healing and reduces wound closure time. Introduction of portable wound therapy devices and their adoption in homecare settings, owing to their easy usability and convenience will boost the segmental share.
 

In terms of application scope, Africa advanced wound care market from diabetic wounds segment was worth USD 40 million in 2017 and is expected to grow considerably during the forecast years. Slow wound healing rate in diabetic patients make them highly prone to microbial and fungal skin infections. High prevalence of diabetes, along with the necessity for critical monitoring of chronic diabetic wounds is bolstering the adoption of advanced wound care solutions in Africa.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2506022/
 

Speaking of the end-use spectrum, homecare settings market share is anticipated to witness a growth of 7.2% by the year 2024. Rising preference for homecare settings across the geriatric population owing to the convenience offered by these settings is favoring the segmental growth.
 

Prominent players of Africa advanced wound care market are Acelity L.P. Inc., BSN Medical, Beiersdorf Global, ConvaTec Group, Hartmann, Coloplast, Smith & Nephew PLC, 3M Inc., B. Braun Melsungen Medical AG, and Mölnlycke Health Care AB.


Frequently Asked Questions (FAQ) :

Rising incidences of bacterial, fungal, and viral infections, along with surging occurrence of STDs such as HIV, and increasing number of road incidents will impel the demand for advanced wound care solutions across Africa.
Wound therapy devices segment is presumed to witness a substantial growth during 2018-2024, as these devices aid in faster healing and reduces wound closure time. Increasing adoption of portable wound therapy devices in homecare settings, owing their easy usability and convenience will boost the segmental share.
Slow wound healing rate in diabetic patients make them highly prone to microbial and fungal skin infections. High prevalence of diabetes, along with the necessity for critical monitoring of chronic diabetic wounds is bolstering the adoption of advanced wound care solutions in Africa.
The prominent industry players are Acelity L.P. Inc., 3M Inc., BSN Medical, Beiersdorf Global, ConvaTec Group, Hartmann, Coloplast, Smith & Nephew PLC, B. Braun Melsungen Medical AG, and Mölnlycke Health Care AB.